Posted by John Perry on Dec 18th, 2025
Climb Bio, Inc. (NASDAQ:CLYM – Get Free Report) Director Ra Capital Management, L.P. bought 101,462 shares of Climb Bio stock in a transaction on Friday, December 12th. The shares were bought at an average price of $2.86 per...
More of this article »